Heterocyclic agents

Details Heterocyclic agents Heterocyclic agents

1989-06-30

1991-07-30

Scalzo, Catherine S. Kilby

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546271, A61K 3144, C07D47300

Patent

active

050360833

ABSTRACT:
The invention concerns a 1,2-dihydro-3H-indazol-3-one derivative of formula I ##STR1## wherein Ra is hydrogen, halogeno, hydroxy, cyano, trifluoromethyl, 1-6C)alkyl or (1-6C)alkoxy;

REFERENCES:
patent: 4045564 (1977-08-01), Berntsson
Chemical Abstracts Service 110: 192811 (abstract of European Patent 284,174).
Kametani et al., "Studies on the Syntheses of Azole Derivatives, Part II(1), Syntheses of N-(1- or 2-Substituted)indazolones via Diazotization (2),", Journal of Heterocyclic Chemistry, vol. 7, No. 4, Aug. 1970, pp. 815-820.
Wyrick et al., "Hypolipidemic Activity of Phthalimide Derivatives, 7, Structure-Activity Studies of Indazolone Analogues", Journal of Medicinal Chemistry, vol. 27, No. 6, Jun. 1984, pp. 768-772.
Chemical Abstracts, vol. 27, No. 21, 20th Nov. 1972, p. 451, abstract No. 140065q.
Chemical Abstracts 4-Indazolinecarboxamide, N-butyl-3-oxo- (7Cl) CAOLD (prior to 1967).
Chemical Abstracts AN CA76(24);147252m.

Affiliated with

Also associated with

Rating

Heterocyclic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1542865